GLP-1 Safety
4 articles in this topic.
GLP-1 Safety
GLP-1 Agonists and Pancreatitis: The Evidence
A meta-analysis of 62 RCTs found a small pancreatitis signal with GLP-1 drugs that vanished when accounting for co-medications. Here is what the data shows.
13 min read|Mar 22, 2026
GLP-1 Safety
GLP-1 Agonists and Retinopathy
Semaglutide raised retinopathy concerns in SUSTAIN-6, but the risk appears tied to rapid glucose lowering, not the drug itself. Here is the full evidence.
13 min read|Mar 22, 2026
GLP-1 Safety
GLP-1 Agonists and Thyroid Cancer Risk
GLP-1 receptor agonists cause thyroid C-cell tumors in rodents but human evidence remains conflicting. Seven studies reveal what the data actually shows.
13 min read|Mar 22, 2026
GLP-1 Safety
Gastroparesis and GLP-1 Drugs: The Evidence
GLP-1 agonists delay gastric emptying by design. When does slowed digestion cross into gastroparesis, how common is it, and what the anesthesia data shows.
13 min read|Mar 21, 2026